文献速递腹部介入CT

影像组学分析可预测肝细胞癌肝移植后复发

Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
PubMed 文献 · Eur J Radiol · 2019-05-10

研究纳入临床确诊肝细胞癌肝移植患者,训练集93例、验证集40例,于CT四期图像勾画感兴趣区提取影像组学特征,用LASSO Cox回归构建影像组学标签,并结合临床危险因素建立联合模型。联合模型列线图对无复发生存预测的C-index在训练集为0.785(95%CI 0.674-0.895),验证集为0.789(95%CI 0.620-0.957),校准曲线显示训练集p=0.121、验证集p=0.164。作者认为CT影像组学标签可能成为预测肝移植后HCC复发的影像生物标志物。

要点

  • 与复发相关的稳定影像组学特征仅见于动脉期和门静脉期。
  • 基于动脉期影像组学特征的预测模型优于门静脉期或两者融合标签。
  • 联合影像组学标签与临床危险因素的列线图对无复发生存预测表现良好(训练集C-index 0.785,验证集0.789)。

核心结论

  • CT图像提取的影像组学标签可能作为肝癌侵袭性的潜在影像生物标志物,并能较准确预测肝移植后HCC复发。

研究设计与样本

  • 研究为影像组学研究,含训练数据集93例和验证数据集40例,均为2011年10月至2016年12月临床确诊的肝移植后HCC患者。
  • 在CT四期图像上勾画病灶感兴趣区提取影像组学特征,采用LASSO Cox回归模型构建影像组学标签。
  • 评估与无复发生存相关的术前临床特征以建立临床模型,并构建联合临床危险因素与影像组学标签的联合模型。

诊断标准与关键数值

  • 联合模型列线图预测无复发生存的C-index在训练数据集为0.785(95%CI 0.674-0.895),在验证数据集为0.789(95%CI 0.620-0.957)。
  • 校准曲线显示训练集p=0.121、验证集p=0.164。
  • 与复发相关的稳定影像组学特征仅见于动脉期和门静脉期;基于动脉期特征的预测模型优于门静脉期或动脉期与门静脉期融合标签。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess whether radiomics signature can identify aggressive behavior and predict recurrence of hepatocellular carcinoma (HCC) after liver transplantation.

METHODS: Our study consisted of a training dataset (n = 93) and a validation dataset (40) with clinically confirmed HCC after liver transplantation from October 2011 to December 2016. Radiomics features were extracted by delineating regions-of-interest (ROIs) around the lesion in four phases of CT images. A radiomics signature was generated using the least absolute shrinkage and selection operator (LASSO) Cox regression model. The association between radiomics signature and recurrence-free survival (RFS) was assessed. Preoperative clinical characteristics potentially associated with RFS were evaluated to develop a clinical model. A combined model incorporating clinical risk factors and radiomics signature was built.

RESULTS: The stable radiomics features associated with the recurrence of HCC were simply found in arterial phase and portal phase. The prediction model based on the radiomics features extracted from the arterial phase showed better prediction performance than the portal vein phase or the fusion signature combining both of arterial and portal vein phase. A radiomics nomogram based on combined model consisting of the radiomics signature and clinical risk factors showed good predictive performance for RFS with a C-index of 0.785 (95% confidence interval [CI]: 0.674-0.895) in the training dataset and 0.789 (95% CI: 0.620-0.957) in the validation dataset. The calibration curves showed agreement in both training (p = 0.121) and validation cohorts (p = 0.164).

CONCLUSIONS: Radiomics signature extracted from CT images may be a potential imaging biomarker for liver cancer invasion and enable accurate prediction of HCC recurrence after liver transplantation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Guo D, Gu D, Wang H, et al. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation. Eur J Radiol. 2019. PMID: 31307650. doi:10.1016/j.ejrad.2019.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。